Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price
₹1,783.00
Market cap
₹4,27,801 Cr
Revenue (annual)
₹58,462 Cr
Net profit (annual)
₹11,479 Cr
P/E (TTM)
35.4×Sector 47.4×
Promoter holding
54.48%+0.00% QoQ
FII holding
14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:58 IST BSE
Merger & Restructuring

Sun Pharmaceutical Industries Merger & Restructuring Worth ₹9.5 Cr

Sun Pharma incorporates a new treasury subsidiary in GIFT City, Gandhinagar. Initial equity subscription is approximately ₹9.50 Crore for group treasury operations.

Value
₹9.50 Cr
08:50 IST BSE
Merger & Restructuring

Sun Pharmaceutical Industries Merger & Restructuring

Sun Pharma announced that Organon stockholders approved the proposed merger, moving the acquisition forward. The deal remains subject to remaining customary closing conditions.

13:23 IST BSE
Merger & Restructuring

Sun Pharmaceutical Industries Merger & Restructuring

Sun Pharmaceutical Industries Limited incorporated a new 100% subsidiary, Sun Pharma America, Inc., in the USA on April 23, 2026. The entity belongs to the pharmaceutical industry and was established for internal group structuring purposes through initial cash consideration.